• 1
    Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007; 25: 5203-5209.
  • 2
    Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010; 10( 11): CD002748.
  • 3
    Adami HO, Bergstrom R, Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer. 1985; 55: 643-647.
  • 4
    Schairer C, Brown LM, Mai PL. Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer. Breast Cancer Res Treat. 2011; 129: 117-124.
  • 5
    Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993; 11: 1545-1552.
  • 6
    Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999; 25: 584-589.
  • 7
    Robbins GF, Berg JW. Bilateral primary breast cancer; a prospective clinicopathological study. Cancer. 1964; 17: 1501-1527.
  • 8
    Rosen PP, Groshen S, Kinne DW, Hellman S. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery. 1989; 106: 904-910.
  • 9
    Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010; 102: 401-409.
  • 10
    Helzlsouer KJ. Contralateral prophylactic mastectomy: quantifying benefits and weighing the harms. J Clin Oncol. 2005; 23: 4251-4253.
  • 11
    Stucky CC, Gray RJ, Wasif N, Dueck AC, Pockaj BA. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol. 2010; 17( suppl 3): 330-337.
  • 12
    Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, et al. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila). 2010; 3: 1026-1034.
  • 13
    Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007; 26: 734-753.
  • 14
    Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques group. In: Proceedings of the 26th Annual SAS Users Group International Conference; April 22-25, 2001; Long Beach, California. Paper 214-26.
  • 15
    Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. 3rd edition. New York, NY: John Wiley & Sons; 2003.
  • 16
    Diggle P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press, 1994.
  • 17
    Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009; 16: 2697-2704.
  • 18
    Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009; 16: 2691-2696.
  • 19
    Narod SA. The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer. Breast Cancer Res Treat. 2011; 128: 581-583.
  • 20
    Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005; 23: 4275-4286.
  • 21
    Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000; 180: 439-445.
  • 22
    Polednak AP. Frequency of prophylactic contralateral mastectomy among breast cancer patients. J Am Coll Surg. 2001; 192: 804-805.
  • 23
    Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009; 16: 1597-1605.
  • 24
    Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010; 17: 2554-2562.
  • 25
    King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011; 29: 2158-2164.
  • 26
    Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004; 22: 2328-2335.